top of page

Latest News

Advocacy

Canadian Cancer Society

May 2, 2026

CCS Rare Cancers Impact Report

Read more
CCS Rare Cancers Impact Report
Featuring:

Dr Rebecca Auer, Dr Carolina Ilkow

Interview

CTV Montreal

Feb 23, 2026

Montreal police officer honours father who died from rare cancer

Read more
Montreal police officer honours father who died from rare cancer
Featuring:

Jonathan Berthiaume, Dr. Simon Turcotte

Interview

CTV News

Feb 17, 2026

Feeling something was a bit off, a doctor went to see his own GP. He was diagnosed with Stage 4 cancer

Read more
Feeling something was a bit off, a doctor went to see his own GP. He was diagnosed with Stage 4 cancer
Featuring:

Terry May, Dr. Arndt Vogel

Patient Experience

Le Devoir

Feb 19, 2026

Les invasions barbares

Read more
Les invasions barbares
Featuring:

Andres Livov

Interview

Le Courrier de Saint-Hyancinte

Feb 19, 2026

Son fils se mobilise pour le développement d’un traitement québécois

Read more
Son fils se mobilise pour le développement d’un traitement québécois
Featuring:

Jonathan Berthiaume

  • Facebook
  • Instagram
  • LinkedIn
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page